FDA-Drug2026-03-11Class IIPROCESSING DEFECT
New Life Pharma semaglutide injection recalled for sterility concerns
OTHEROH
Stop using New Life Pharma semaglutide injection
New Life Pharma LLC is recalling specific lots of semaglutide injection (Nomida brand) because the company cannot confirm the medication was made under sterile conditions. The affected lots are 241113 (expires 11/30/2026) and 250103 (expires 1/31/2027). A total of 820 vials were distributed in Ohio.
- Check your semaglutide vial for lot number 241113 or 250103.
- If you have an affected lot, stop using it and contact your doctor or pharmacist immediately.
- Do not use the medication. Return it to your pharmacy.
- Call your doctor if you have already used this medication and have concerns.
Hazard
Lack of Assurance of Sterility
Sold states
OH
Affected count
820 vials
Manufactured in
265 Livingston St, N/A, Northvale, NJ, United States
Products
Semaglutide Inj, 2mg x 10, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-001-07.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0392-2026Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief